Electrolytes supplementation can decrease the risk of nephrotoxicity in patients with solid tumors undergoing chemotherapy with cisplatin.

Omary M S MinziTatu E LyimoFrancis F FuriaAlphonce I MarealleManase KilonziGeorge M BwireChristina Malichewe

Published in: BMC pharmacology & toxicology (2020)

Electrolytes supplementation decreases the risk of nephrotoxicity after chemotherapy with cisplatin. A randomized controlled trial with a larger sample size is recommended to evaluate the robustness of these findings.

Keyphrases

ionic liquid
locally advanced
solid state
drug induced
ion batteries
rectal cancer